Studies * EuroSIDA * Presentations * 2016
Presentations 2016

AASLD The Liver Meeting, Boston 11-15 November 2016

Poster Presentation:
Uptake of HCV treatment in HIV/HCV coinfected patients across Europe in the era of direct-acting antivirals, Presented by Lars Peters. POSTER

HIV Drug Therapy Glasgow 2016, 23-26 October 2016

Oral Presentation:
Persistent disparities in meeting WHO/UNAIDS targets for ART coverage and ART-induced HIV RNA suppression across Europe, presented by Kamilla. PRESENTATION WEBCAST

Thistle Poster Presentations:
The extent of B-cell activation and dysfunction preceding lymphoma development, presented by Alvaro Borges on behalf of Leah Shepherd. P189 POSTER

Aging and the evolution of comorbidities among HIV patients in the EuroSIDA cohort, presented by Sara Lopes. P154 POSTER

21st International AIDS Conference, Durban 18-22 July 2016

Poster Presentation:
Opportunistic diseases among HIV+ people with CD4 counts > 500/mm3: a EuroSIDA study, presented by Alvaro Borges for EuroSIDA in EuroCoord PRESENTATION

16th International Conference for integrated Care Model Barcelona, Spain 23-25 May 2016

Oral Presentation:

People-centred health services at HIV clinics across Europe: findings from the EuroSIDA clinic survey, presented by JV Lazarus, K Safreed-Harmon. PRESENTATION

Conference on Retroviruses and Oppertunistic Infections (CROI) 22-25 February 2016

Oral Presentation:
Antiretrovirals, fractures and osteonecrosis in a large European HIV cohort, presented by Alvaro Borges on behalf of EuroSIDA in EuroCoord. O-4/46. PRESENTATION WEBCAST

Poster presentations:
Influence of Transmitted Drug Resistance on CD4 Decline among ART Naïve HIV Patients, presented by Anna Schultze on behalf of EuroSIDA in EuroCoord, the EU-Resist collaborating network and the ViroLAB collaboration. P-L1/486. PRESENTATION

Risk factors for Hodgkin (HL) and non-Hodgkin lymphoma (NHL) in Europe, presented by Leah Shepherd on behalf of EuroSIDA in EuroCoord. P-03/630. PRESENTATION